| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
26,085 |
24,188 |
$1.66M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,116 |
20,150 |
$1.01M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,550 |
2,522 |
$242K |
| 64483 |
|
2,207 |
2,184 |
$173K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,570 |
1,552 |
$149K |
| 64635 |
|
966 |
952 |
$148K |
| 64493 |
|
2,161 |
2,059 |
$137K |
| 99490 |
Ccm add 20min |
4,161 |
4,146 |
$106K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,149 |
1,135 |
$102K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,445 |
1,439 |
$94K |
| 64636 |
|
1,891 |
900 |
$78K |
| 64494 |
|
2,067 |
1,939 |
$69K |
| 01936 |
|
1,123 |
1,071 |
$58K |
| 64490 |
|
803 |
777 |
$52K |
| 95886 |
|
613 |
498 |
$34K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
670 |
664 |
$27K |
| 64491 |
|
768 |
740 |
$25K |
| 99457 |
|
968 |
956 |
$21K |
| 64495 |
|
516 |
488 |
$19K |
| 99439 |
|
571 |
568 |
$15K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,692 |
1,634 |
$12K |
| 99442 |
|
348 |
341 |
$12K |
| 20611 |
|
231 |
208 |
$8K |
| 76942 |
|
335 |
323 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,158 |
1,068 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,475 |
1,440 |
$6K |
| 96127 |
|
2,071 |
2,002 |
$6K |
| 64484 |
|
173 |
171 |
$5K |
| 64492 |
|
134 |
133 |
$5K |
| 62321 |
|
86 |
86 |
$4K |
| 99152 |
|
545 |
540 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
141 |
137 |
$4K |
| 99454 |
|
210 |
206 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
154 |
150 |
$4K |
| G9007 |
Coordinated care fee, scheduled team conference |
203 |
106 |
$4K |
| 99495 |
|
49 |
49 |
$4K |
| 27096 |
|
123 |
120 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
33 |
32 |
$4K |
| 90686 |
|
159 |
159 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
53 |
51 |
$2K |
| G9002 |
Coordinated care fee, maintenance rate |
46 |
38 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,345 |
1,068 |
$2K |
| 99458 |
|
140 |
136 |
$2K |
| 81002 |
|
798 |
763 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
199 |
192 |
$2K |
| 20610 |
|
124 |
104 |
$2K |
| 99441 |
|
58 |
54 |
$1K |
| 20553 |
|
60 |
59 |
$1K |
| 01992 |
|
24 |
14 |
$977.20 |
| 98966 |
|
372 |
287 |
$906.84 |
| 95909 |
|
15 |
15 |
$863.15 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,496 |
1,461 |
$830.18 |
| 90658 |
|
68 |
64 |
$693.57 |
| 90674 |
|
30 |
30 |
$683.39 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
28 |
12 |
$661.33 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
485 |
460 |
$641.80 |
| 93000 |
|
67 |
65 |
$523.60 |
| 99426 |
|
15 |
15 |
$477.92 |
| G0008 |
Administration of influenza virus vaccine |
100 |
98 |
$469.70 |
| 0011A |
|
12 |
12 |
$431.80 |
| 99406 |
|
60 |
58 |
$357.48 |
| 71046 |
Radiologic examination, chest; 2 views |
30 |
27 |
$350.07 |
| 20552 |
|
12 |
12 |
$223.02 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
47 |
47 |
$167.45 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16 |
16 |
$166.78 |
| 99453 |
|
27 |
26 |
$164.40 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
13 |
$144.04 |
| J3490 |
Unclassified drugs |
20 |
20 |
$131.26 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
38 |
37 |
$107.83 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
19 |
19 |
$93.46 |
| 81025 |
|
14 |
12 |
$91.62 |
| Q2035 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) |
56 |
54 |
$89.00 |
| 3078F |
|
3,642 |
3,295 |
$3.81 |
| 3074F |
|
3,921 |
3,503 |
$3.57 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
326 |
323 |
$2.90 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
49 |
49 |
$2.88 |
| 3079F |
|
2,176 |
2,057 |
$2.72 |
| 3075F |
|
1,523 |
1,431 |
$2.32 |
| 3077F |
|
652 |
621 |
$1.01 |
| 3080F |
|
282 |
267 |
$0.39 |
| 1160F |
|
15 |
15 |
$0.00 |
| 1111F |
|
26 |
25 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
36 |
36 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
22 |
19 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
13 |
13 |
$0.00 |